Fungal infections include a wide range of opportunistic and invasive diseases. Two of four
major fatal diseases in patients with human immunodeficiency virus (HIV) infection are …

Diseases caused by fungi can occur in healthy people, but immunocompromised patients
are the major risk group for invasive fungal infections. Cases of fungal resistance and the …

Paracoccidioides brasiliensis and P. lutzii are etiologic agents of paracoccidioidomycosis
(PCM), an important endemic mycosis in Latin America. During its evolution, these fungi …

After viruses and bacteria, fungal infections remain a serious threat to the survival and well-
being of society. The continuous emergence of resistance against commonly used anti …

This discussion is intended to be an overview of current advances in the development of
fungal cell wall vaccines with an emphasis on Candida; it is not a comprehensive historical …

Fungal infections represent a serious global health problem, causing damage to health and
the economy on the scale of millions. Although vaccines are the most effective therapeutic …

Nanostructured materials including mesoporous silica nanoparticles (MSNs) have attracted
attention due to their recently discovered capability to increase the immune responses …

Vaccines have been hailed as one of the greatest achievements in the public health during
the past century. The global eradication of Smallpox virus in humans and Rinderpest virus in …

The finding that some mAbs are antifungal suggests that antibody immunity may play a key
role in the defense of the host against mycotic infections. The discovery of antibodies that …

Paracoccidioidomycosis (PCM), caused by Paracoccidioides spp, is an important endemic
mycosis in Latin America. There are two recognized Paracoccidioides species, P …